Neurostimulation Devices Market

1
Neurostimulation Devices Market Analysis by
Product, Application Type (Pain Management,
Epilepsy, Essential Tremor, Urinary and Fecal
Incontinence, Depression, Dystonia,
Gastroparesis, Parkinson's Disease) Type and End
User Forecast to 2026
www.reportsanddata.com
2
Market Summary
According to the current analysis of Reports and
Data, the global Neurostimulation Devices market
was valued at USD 4.98 Billion in 2018 and is
expected to reach USD 12.7 Billion by the year
2026, at a CAGR of 12.4 . Neurostimulation
Devices - Neurostimulator or Neurostimulation are
equipment that is used for neuromodulation. The
process of making use of an implantable medical
device to alter and modulate neural activities
for therapeutic purposes is called
neuromodulation. The recent emergence of
Neurostimulation Devices as a neural activity
modulator is a major disruptive finding in the
healthcare sector. In line with this, market
leaders, as well as emerging players, are
developing mechanisms that can be used for neural
activities modulation. For instance, Medtronic
plc US-based medical device company launched
EnterraII gastric neurostimulator, a programmable
device that generates mild electrical pulses for
gastric electrical stimulation to treat chronic,
intractable nausea and vomiting due to
gastroparesis. Rising prevalence of chronic
diseases and lifestyle health disorders, unmet
needs of patients are pushing the technological
development, significant focus of healthcare
companies on development of novel mechanisms,
upcoming patent expiry, availability of private
as well public funds for research, and
affirmative regulatory scenario all over the
globe, are some of the notable factors boosting
market growth in the industry. According to the
American Academy of Neurology, stroke is listed
as the third leading cause of death in U.S., with
Alzheimers being ranked as the sixth leading
cause of death. Statistics from the same source
indicate that Parkinsons affects nearly 1
million Americans annually with at least a
minimum of 60,000 new cases that are reported
annually.
www.reportsanddata.com
3

• Further key findings from the report suggest
• Neurostimulation Devices market is growing at a
  CAGR of 13.6 in the Asia Pacific, followed by
  North America and Europe, with 12.3 and 12.1
  CAGR, respectively. Rising chronic disease
  prevalence across the globe is the prominent
  factor to accelerate the Neurostimulation Devices
  market growth during forecast period across all
  regions
• As of 2018, Spinal Cord Stimulators is the
  dominating Neurostimulation Devices, which holds
  35.5 of the global market. European regional
  market is the chief revenue-generating source for
  this product segment, followed by North America,
  Asia-Pacific, and other regions
• Sacral Nerve Stimulators is expected to be the
  fastest-growing market segment during the
  forecast period 2019-2026, with a CAGR of 13.2.
  However, associated stringent government
  regulation is a major challenge for the
  Neurostimulation Devices market growth of this
  market segment
• Pain Management application type segment was
  valued at USD 2.03 billion in 2018 and is
  expected to reach USD 5.3 billion by 2026
• The Asia Pacific is expected to account for 19.4
  of the global Neurostimulation Devices market.
  Developing nations such as China and India are
  likely to observe high growth

www.reportsanddata.com
4

• Associated adverse effects related to
  Neurostimulation Devices and Availability of
  external substitutes is expected to hinder the
  market growth during the forecast period
• Key participants in Neurostimulation Devices
  include Medtronic PLC, BioControl Medical, St.
  Jude Medical, Spinal Modulation, Boston
  Scientific Corp., Synapse Biomedical Inc.,
  Cochlear, Cyberonics, Inc., and Nevro Corp.
• Free Report Sample PDF _at_ https//www.reportsanddat
  a.com/sample-enquiry-form/2303
• Segments covered in the report
• This report forecasts revenue growth at a global,
  regional country level, and provides an
  analysis of the market trends in each of the
  sub-segments from 2016 to 2026. For the purpose
  of this report, Reports and Data has segmented
  the Neurostimulation Devices market on the basis
  of type, Product type, Application type, end use,
  and region
• Product Type (Revenue, USD Million 20162026)
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators

www.reportsanddata.com
5

• Vagus Nerve Stimulators
• Gastric Electric Stimulators
• Application Type (Revenue, USD Million
  20162026)
• Pain Management
• Epilepsy
• Essential Tremor
• Urinary and Fecal Incontinence
• Depression
• Dystonia
• Gastroparesis
• Parkinson's Disease
• Others
• Type (Revenue, USD Million 20162026)
• Implantable
• External

www.reportsanddata.com
6

• Cognitive Care Centers
• Research Institutes
• Others
• Regional Outlook (Revenue in USD Million
  20162026)
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Spain
• Benelux
• Italy
• Rest of the Europe
• Asia Pacific

www.reportsanddata.com
7

• Taiwan
• Australia
• Rest of Asia-Pacific
• Middle East Africa
• Saudi Arabia
• South Africa
• Egypt
• Israel
• Rest of MEA
• Latin America
• Brazil
• Argentina
• Rest of Latin America
• Browse Complete Report _at_ https//www.reportsanddat
  a.com/report-detail/neurostimulation-devices-marke
  t

www.reportsanddata.com
8
About Us
Reports and Data is a market research and
consulting company that provides syndicated
research reports, customized research reports,
and consulting services. Our solutions purely
focus on your purpose to locate, target and
analyze consumer behavior shifts across
demographics, across industries and help clients
make a smarter business decision. We offer
market intelligence studies ensuring relevant and
fact-based research across a multiple industries
including Healthcare, Technology, Chemicals,
Power, and Energy. We consistently update our
research offerings to ensure our clients are
aware about the latest trends existent in the
market. Reports and Data has a strong base of
experienced analysts from varied areas of
expertise.
Contact US
John Watson Head of Business Development Reports
And Data Web www.reportsanddata.com Direct
Line 1-212-710-1370 E-mail sales_at_reportsanddata
.com
www.reportsanddata.com